Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Clinical trial NCT00393224 · TERMINATED

Trial details

NCT number: NCT00393224
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Study type: OBSERVATIONAL

Nasopharyngeal Neoplasms

Start date: 2005-07-05
Primary completion: 2020-06-02
Enrollment: 952

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.